within Pharmacolibrary.Drugs.ATC.D;

model D01AC03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00016666666666666666,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.04,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D01AC03</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Econazole is an imidazole class antifungal agent primarily used in topical formulations for the treatment of superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. It works by inhibiting ergosterol synthesis, a vital component of fungal cell membranes. It is currently approved and widely used in topical form, but not for systemic administration.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult humans following topical administration, as systemic pharmacokinetics are not typically reported due to negligible absorption.</p><h4>References</h4><ol><li><p>Bahl, D, et al., &amp; Kahaleh, B (2019). Evaluation of topical econazole nitrate formulations with potential for treating Raynaud&#x27;s phenomenon. <i>Pharmaceutical development and technology</i> 24(6) 689–699. DOI:<a href=\"https://doi.org/10.1080/10837450.2019.1578371\">10.1080/10837450.2019.1578371</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30712434/\">https://pubmed.ncbi.nlm.nih.gov/30712434</a></p></li><li><p>Daftardar, S, et al., &amp; Kahaleh, B (2020). Ultrasound-mediated topical delivery of econazole nitrate with potential for treating Raynaud&#x27;s phenomenon. <i>International journal of pharmaceutics</i> 580 119229–None. DOI:<a href=\"https://doi.org/10.1016/j.ijpharm.2020.119229\">10.1016/j.ijpharm.2020.119229</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32184178/\">https://pubmed.ncbi.nlm.nih.gov/32184178</a></p></li><li><p>Singh, S, et al., &amp; Masand, N (2024). Nanotechnology-based Drug Delivery of Topical Antifungal Agents. <i>Pharmaceutical nanotechnology</i> 12(3) 185–196. DOI:<a href=\"https://doi.org/10.2174/2211738511666230818125031\">10.2174/2211738511666230818125031</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37594096/\">https://pubmed.ncbi.nlm.nih.gov/37594096</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D01AC03;
